Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$788 Hold
5
﹤0.01% 527
2022
Q1
$894 Hold
5
﹤0.01% 809
2021
Q4
$1.02K Hold
5
﹤0.01% 709
2021
Q3
$910 Hold
5
﹤0.01% 872
2021
Q2
$871 Sell
5
-60
-92% -$10.3K ﹤0.01% 891
2021
Q1
$10.8K Sell
65
-539
-89% -$80.5K ﹤0.01% 595
2020
Q4
$79.6K Buy
604
+598
+9,967% +$78.3K 0.02% 424
2020
Q3
$717 Hold
6
﹤0.01% 651
2020
Q2
$697 Hold
6
﹤0.01% 587
2020
Q1
$560 Hold
6
﹤0.01% 586
2019
Q4
$867 Hold
6
﹤0.01% 553
2019
Q3
$739 Sell
6
-36
-86% -$4.13K ﹤0.01% 557
2019
Q2
$4.66K Hold
42
﹤0.01% 479
2019
Q1
$4.05K Hold
42
﹤0.01% 418
2018
Q4
$3.4K Hold
42
﹤0.01% 508
2018
Q3
$3.73K Sell
42
-14,446
-100% -$1.25M ﹤0.01% 470
2018
Q2
$1.17M Buy
+14,488
New +$1.12M 0.2% 114

Other funds holding CDW

Exane Derivatives's CDW Position: Q2 2022 in Review

Exane Derivatives held its CDW (CDW) position steady in Q2 2022 at 5 shares worth $788. The position accounts for ﹤0.01% of the portfolio, ranked #527.

Exane Derivatives first reported a position in CDW in Q2 2018 and has held it in 17 quarters since. The position peaked at $1.17M in Q2 2018. 776 funds tracked by Wall St. Rank hold CDW as of Q2 2022.

  • Exane Derivatives held 5 shares of CDW worth $788 as of Q2 2022.
  • Exane Derivatives left its CDW share count unchanged in Q2 2022.
  • CDW made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #527 holding.
  • Exane Derivatives first reported a position in CDW in Q2 2018 and has held it in 17 quarters since.
  • Exane Derivatives's CDW position peaked at $1.17M in Q2 2018.
  • 776 funds tracked by Wall St. Rank held CDW as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.